Cargando…
Building a better neonatal mouse model to understand infant respiratory syncytial virus disease
BACKGROUND: Respiratory syncytial virus (RSV) is the number one cause of lower respiratory tract infection in infants; and severe RSV infection in infants is associated with asthma development. Today, there are still no vaccines or specific antiviral therapies against RSV. The mechanisms of RSV path...
Autores principales: | You, Dahui, Siefker, David T., Shrestha, Bishwas, Saravia, Jordy, Cormier, Stephania A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531813/ https://www.ncbi.nlm.nih.gov/pubmed/26231396 http://dx.doi.org/10.1186/s12931-015-0244-0 |
Ejemplares similares
-
Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy
por: Hijano, Diego R., et al.
Publicado: (2018) -
Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33
por: Saravia, Jordy, et al.
Publicado: (2015) -
Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants
por: Huang, Huaqiong, et al.
Publicado: (2014) -
Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
por: Harding, Jeffrey N., et al.
Publicado: (2020) -
A Neonatal Murine Model of MRSA Pneumonia
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2017)